Interor is a trusted and innovative brand that specializes in developing efficient processes for processing products under Controlled Drug Administration (CDA) for catalog products. With a range of advanced technologies, Interor ensures optimal reactivity and flexibility in the development of complex molecules. Located in Calais, France, the company serves primarily large pharmaceutical and chemical groups, offering exceptional levels of research and development (R&D) capabilities and a state-of-the-art industrial site that adheres to the highest quality standards.

Interor's rich history spans back to its establishment in 1975, and it has since grown significantly through continuous investments in infrastructure and facility upgrades. In December 2020, the company was acquired by Turenne Groupe, allowing for further growth, modernization, and enhanced customer support. With 145 dedicated employees and a commitment to cGMP standards since 1976, Interor guarantees its clients an independent, close, and dependable partnership.

Contact Interor today for trusted solutions in products, technologies, and R&D